Labcorp (LH)
Provides clinical diagnostics and global laboratory support for biopharma research.
$311.77
vs last close+0.23 (+0.07%)
Something off on this page? Send us feedback.
Next report
Oct 27, 26
in 34 days
EPS estimate
$4.65
Revenue estimate
$3.76B
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$3.45$3.84$4.35$4.18$4.07$4.25$4.99Pending
Estimate$3.39$3.74$4.17$4.13$3.95$4.11$4.78$4.65
Surprise+1.8%+2.7%+4.3%+1.2%+3.0%+3.4%+4.4%—
RevenueReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$3.33B$3.35B$3.53B$3.56B$3.52B$3.54B$3.73BPending
Estimate$3.31B$3.40B$3.49B$3.56B$3.56B$3.51B$3.71B$3.76B
Surprise+0.7%−1.6%+1.2%+0.2%−1.2%+0.8%+0.6%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $5.36 | — | — |
| Sep 2028 | $5.33 | — | — |
| Jun 2028 | $5.46 | — | — |
| Mar 2028 | $4.92 | — | — |
| Dec 2027 | $4.92 | — | — |
| Sep 2027 | $5.03 | — | — |
| Jun 2027 | $5.22 | — | — |
| Mar 2027 | $4.61 | — | — |
| Dec 2026 | $4.45 | — | — |
| Oct 2026 | $4.65 | — | — |
| Jul 2026 | $4.78 | $4.99 | +4.4% |
| Apr 2026 | $4.11 | $4.25 | +3.4% |
| Feb 2026 | $3.95 | $4.07 | +3.0% |
| Oct 2025 | $4.13 | $4.18 | +1.2% |
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $5.36 | — | — | $4.05B | — | — | — |
| Sep 2028 | $5.33 | — | — | $4.09B | — | — | — |
| Jun 2028 | $5.46 | — | — | $4.04B | — | — | — |
| Mar 2028 | $4.92 | — | — | $3.85B | — | — | — |
| Dec 2027 | $4.92 | — | — | $3.89B | — | — | — |
| Sep 2027 | $5.03 | — | — | $3.93B | — | — | — |
| Jun 2027 | $5.22 | — | — | $3.90B | — | — | — |
| Mar 2027 | $4.61 | — | — | $3.71B | — | — | — |
| Dec 2026 | $4.45 | — | — | $3.72B | — | — | — |
| Oct 27, 2026 | $4.65 | — | — | $3.76B | — | — | — |
| Jul 30, 2026 | $4.78 | $4.99 | +4.4% | $3.71B | $3.73B | +0.6% | +2.7% |
| Apr 30, 2026 | $4.11 | $4.25 | +3.4% | $3.51B | $3.54B | +0.8% | −0.1% |
| Feb 17, 2026 | $3.95 | $4.07 | +3.0% | $3.56B | $3.52B | −1.2% | −2.1% |
| Oct 28, 2025 | $4.13 | $4.18 | +1.2% | $3.56B | $3.56B | +0.2% | −5.8% |
| Jul 24, 2025 | |||||||
| Apr 29, 2025 | |||||||
| Feb 6, 2025 | |||||||
| Oct 24, 2024 | |||||||
| Aug 1, 2024 | |||||||
| Apr 25, 2024 | |||||||
| Feb 15, 2024 | |||||||
| Oct 26, 2023 | |||||||
| Jul 27, 2023 | |||||||
| Apr 25, 2023 | |||||||
| Feb 16, 2023 | |||||||
| Oct 27, 2022 | |||||||
| Jul 28, 2022 | |||||||
| Apr 28, 2022 | |||||||
| Feb 10, 2022 | |||||||
| Oct 28, 2021 | |||||||
| Jul 29, 2021 | |||||||
| Apr 29, 2021 | |||||||
| Feb 11, 2021 | |||||||
| Oct 27, 2020 | |||||||
| Jul 28, 2020 | |||||||
| Apr 29, 2020 | |||||||
| Feb 13, 2020 | |||||||
| Oct 24, 2019 | |||||||
| Jul 25, 2019 | |||||||
| Apr 30, 2019 | |||||||
| Feb 7, 2019 | |||||||
| Oct 24, 2018 | |||||||
| Jul 25, 2018 | |||||||
| Apr 25, 2018 | |||||||
| Feb 6, 2018 | |||||||
| Oct 25, 2017 | |||||||
| Jul 26, 2017 | |||||||
| Apr 25, 2017 | |||||||
| Feb 16, 2017 | |||||||
| Oct 26, 2016 | |||||||
| Jul 27, 2016 | |||||||
| Apr 25, 2016 | |||||||
| Feb 18, 2016 | |||||||
| Oct 26, 2015 | |||||||
| Jul 28, 2015 |